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ABSTRACT
One of the major challenges in the post-genome era
is the correlation between genes and function or
phenotype. We have pioneered a strategy for
screening of cDNA libraries, which is based on
sequential combination of lentiviral and oncoretro-
viral expression systems and can be used to identify
proliferation-modulating genes. Screening of a lenti-
viral expression library derived from adult human
brain cDNA resulted in cloning of the potent prolifer-
ation-inducing determinant termed pi1 (proliferation
inducer 1). Transduction experiments using GFP-
expressing oncoretroviruses to target proliferation-
competent cells suggested that overexpression of
pi1 initiates proliferation of human umbilical vein
endothelial cells (HUVECs). Growth induction of
HUVECs as well as Swiss3T3 ®broblasts was con-
®rmed by Brd-uridine incorporation assays, which
correlated increased DNA synthesis with expression
of pi1. The identi®ed pi1 cDNA is 297 bp long and
encodes a 10 kDa polypeptide. Since deregulation
of proliferation control accounts for a number of
today's untreatable human diseases such as neuro-
degenerative disorders and cancer, discovery of
novel proliferation-modulating genes is essential for
developing new strategies for gene therapy and
tissue engineering.
INTRODUCTION
Expression cloning has a track record in discovering novel
genes based on their function. Typically, identi®cation of a
single gene consists of several screening rounds of a cDNA
expression library for a speci®c trait, such as proliferation, DNA
binding or cell surface expression. Successful expression
cloning of proliferation-inducing genes requires ef®cient trans-
fer of cDNA pools into mitotically inactive primary cells. We
suggest cDNA libraries engineered into a lentiviral expression
setting to be the preferred con®guration for functional
expression cloning. Retroviruses are lipid-enveloped particles
comprising a homodimer of linear, positive-sense, single-
stranded RNA genomes that replicate via a DNA intermediate
(1). Oncoretroviral and lentiviral vectors exhibit a large cloning
capacity and enable long-term expression of desired transgenes
following integration into the target chromosomes. Pseudo-
typing of transgenic retroviral particles extends their tropism
and increases their transduction ef®ciency. The multitropism of
VSV-G-pseudotyped lentiviruses facilitates screening of a
single lentiviral cDNA expression library in a variety of
different cells or tissues. Although very similar in their genetic
set-up, oncoretroviruses only infect dividing cells whereas
lentiviruses can infect and replicate in non-mitotic cells (2,3).
Typically, oncoretroviral/lentiviral transduction rates are a
function of the multiplicity of infection (m.o.i.). Depending
on the m.o.i., the fraction of transduced cells can vary from 1 to
95%. By increasing the m.o.i., a single cell can be transduced by
more than one cDNA-encoding viral particle, resulting in
coexpression of a gene pool. This retroviral characteristic
enables elucidation of combinatorial effects of several genes
coexpressed in a single target cell.
Most of today's available lentiviral expression vectors have
been designed by eliminating pathogenic transcription units
from the viral genome while retaining cis-acting elements
essential for packaging and reverse transcription. Transgenic
non-pathogenic and replication-incompetent lentiviral par-
ticles are produced following cotransfection of three separate
vectors into a helper cell line: (i) the transfer construct
containing viral cis-acting elements as well as the desired
transgene, (ii) the packaging construct encoding structural and
(iii) envelope proteins (4). In order to increase biosafety and
reduce promoter interference, self-inactivating (SIN) lenti-
vectors have become the standard for transduction of
proliferation-inert cells. The SIN lentiviruses harbor a deletion
in their 3¢ LTR that results in inactivation of 5¢ LTR-
associated promoter/enhancer activities following reverse
transcription and integration into the target chromosome (5).
Recently, we have engineered a series of self-inactivating
lentiviral vectors which contain (i) unmatched polylinkers
with up to 29 unique sites for restriction endonucleases,
(ii) strong promoters derived from human cytomegalovirus
immediate-early or the human elongation factor 1a promoters
and/or (iii) tricistronic expression cassettes for coordinated
expression of up to three transgenes (6).
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Cell proliferation failures are associated with a number of
human pathologies including multiple sclerosis, osteoarthritis
as well as Parkinson's and Alzheimer's disease. Cloning of
novel proliferation-inducing genes may have therapeutic
implications for tissue regeneration as well as the treatment
of tissue-degenerative disorders. We have developed an
expression cloning strategy for the discovery of growth-
promoting determinants using a combination of retroviral and
lentiviral transduction technologies. Screening of a human
brain cDNA library expressed in human umbilical vein
endothelial cells (HUVEC) resulted in the identi®cation of
pi1, a novel proliferation-inducing cDNA.
MATERIALS AND METHODS
Cell culture
HEK293-T (6), Swiss3T3 ®broblasts (provided by Urs
Ziegler) and HeLa (ATCC CCL-2) cells were cultured in
Dulbecco's modi®ed Eagle's medium (Invitrogen, Carlsbad,
CA) supplemented with 10% heat-inactivated fetal calf serum
(FCS) (PAA, Vienna, Austria; lot no. A01129-242), 100 U
penicillin and 100 mg/ml streptomycin (Sigma Chemicals,
St Louis, MO) in a humidi®ed atmosphere containing 5% CO2
at 37°C. HUVECs were dissected and cultured as previously
described (7). HUVECs of the ®rst passages were used. Cells
were transfected using either calcium phosphate-based proto-
cols or FuGENE6 transfection reagent (Roche Molecular
Biochemicals, Rotkreuz, Switzerland).
FACS analysis
Cells were dissociated from the culture dish by trypsinization,
resuspended in PBS containing 1% FCS and the ¯uorescence
was quanti®ed using a Beckman Counter EPICS XL ¯ow
cytometer (Beckman Coulter Intl. SA, Nyon, Switzerland).
Genomic DNA isolation
Cells (5 3 105) were washed, collected in PBS and pelleted. The
cells were lysed in lysis buffer (10 mM Tris±Cl; 50 mM KCl;
1.5 mM MgCl2; 0.45% Tween 20; 0.5% Triton X-100) and
proteinase K (Qiagen, Basel, Switzerland) was added to the
lysate for 45 min at 50°C. The DNA was puri®ed by phenol/
chloroform extraction followed by ethanol precipitation.
Cell proliferation assay
Cell proliferation assay using Brd-uridine incorporation was
performed using the Cell Proliferation ELISA kit (Roche
Molecular Biochemicals, Rotkreuz, Switzerland) according to
the manufacturer's instruction. In brief, cells were seeded
into 96-well plates at different concentrations, allowed to
adhere for 24 h and transfected with either the pPI1-His or
isogenic control vectors. Proliferation was quanti®ed 36 h
post-transfection.
Western blotting
Bacterial lysates were resolved on SDS±polyacrylamide gels
and transferred to Immobilon-P membranes (Millipore
Corporation, Bedford, MA) using standard procedures. The
membrane was blocked with 4% (w/v) instant non-fat milk
powder (Coop, Switzerland) and incubated for 2 h with anti-
His antibodies (Novagen, Madison, WI) diluted in PBS
containing 4% non-fat milk powder. His-tagged proteins
were visualized following incubation with goat anti-mouse
horseradish peroxidase-coupled antibody and ECL detection
reagents (Amersham Biosciences, UK).
Construction of plasmids and the cDNA library
The lentiviral expression vector pDC32 was constructed by
cloning the PhCMV-encoding BamHI/KpnI fragment, PCR-
ampli®ed from pcDNA3.1/V5-His-TOPO (Invitrogen,
Carlsbad, CA), BamHI/KpnI into pMF388 (6). The following
primers were used for ampli®cation of PhCMV: ODC1: 5¢-
GGGGTACCGCCAGATATACGCGTTGACA-3¢ and ODC2
5¢-CGGGATCCACGTGAGCCAGTAAGCAGTGGGTTC-3¢
(annealing sequences are underlined, extensions containing
KpnI and BamHI/PmlI restriction sites are shown in bold). The
double-stranded (ds) cDNA library was constructed from
human adult brain total RNA (Invitrogen, Carlsbad, CA)
using the NotI-containing oligo-d(T) for priming and the
Copy Kit cDNA synthesis system (Invitrogen, Carlsbad, CA)
according to the manufacturer's protocol. The ds cDNA was
blunted using DNA polymerase I followed by NotI digestion
and gel puri®cation. The NotI-digested ds cDNA was ligated
into the NotI±PmlI sites of pDC32 resulting in the lentivector-
based cDNA library. The lentivector-encoded cDNA library
was converted into replication-incompetent lentiviral particles
following recently described protocols (6). The titer of the
library was determined using the p24 ELISA assay (NEK-050,
Perkin Elmer, Boston, MA).
Transduced cDNA inserts of interest were PCR-ampli®ed
from the genomic DNA using primers ODC3: 5¢-GAGACA-
GAGACAGATCCATTCG-3¢ (annealing to nucleotides
2372±2393 of pMF388) and ODC4: 5¢-CGTGTACGGTGG-
GAGGTCTA-3¢ [annealing to nucleotides 786±805 of
pcDNA3.1/V5HisTOPO (corresponding to PhCMV)] and the
following PCR program: annealing temperature of the ®rst
two cycles was 64°C which was subsequently decreased by
2°C per two cycles until a ®nal annealing temperature of 54°C
was reached. At 54°C an additional 20 cycles were run. The
products of the ®rst ampli®cation round were diluted 1:20 in
H2O and used as template for the second PCR employing
identical primers and reaction conditions. The ®nal PCR
product was subcloned into pcDNA3.1/V5-His-TOPO
(Invitrogen, Carlsbad, CA) to result in pPCR102-2. The
novel cDNA sequence contained within pPCR102-2 has been
deposited in the GenBank database (accession no.
AY255855). All PCR reactions were conducted using
DyNAzyme.EXT polymerase (Finnzymes, Oulu, Finland).
pND-A2 and pND-A8 represent nested deletions of pPCR102-2
which were performed by restricting pPCR102-2 with KpnI
and BamHI followed by Exonuclease III (NEB, Beverly, MA)
mediated digestion at 37°C for 1, 2 and 3 min, respectively.
The Exonuclease III reaction was stopped in liquid nitrogen
and the enzyme was subsequently heat inactivated. The
digestion products were blunted using Mung Bean Nuclease
(BD Biosciences, Palo Alto, CA) and recircularized followed
by bacterial transformation and plasmid DNA puri®cation.
The pPI1-His construct was obtained by PCR-mediated
ampli®cation of pi1 from pPCR102-2 using primers OD5:
5¢-CGGGATCCATGGATCTGTCTCAGTCTCAGTCTC-3¢
and OD6: 5¢-CCCGATATCAGACAGAGACAATCCATT-
CGAACAGA-3¢, (annealing sequences are underlined and
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extensions containing BamHI and EcoRV restriction sites are
shown in bold) followed by cloning of the BamHI/EcoRV-
digested pi1-encoding PCR product into BamHI/EcoRV-
restricted pEF6/V5-His-TOPO (Invitrogen, Carlsbad, CA),
in-frame with histidine tag and stop codon. The prokaryotic
pi1 expression vector pDC106 was constructed by PCR-
mediated ampli®cation of pi1 from pPI1-His using OD7: 5¢-
CACCATGGATCTGTCTCAGTCTCAGTCTC-3¢ and OD8:
5¢-AACTAGAAGGCACAGTCGAGGCTG-3¢ (annealing
sequences are underlined). OD8 corresponds to nucleotides
1108±1131 of pcDNA3.1/V5-His-TOPO (Invitrogen, Carlsbad,
CA) and OD7 to nucleotides 1±25 of the pi1. The PCR product
was puri®ed and cloned into the prokaryotic expression vector
pET101-D (Invitrogen, Carlsbad, CA). The oncoretroviral
vector pLEGFP-N1 encoding the enhanced green ¯uorescent
protein (GFP) was obtained from BD Biosciences (Palo Alto,
CA).
Lentivirus and oncoretrovirus production
Lentiviruses were produced as described previously (6). In
brief, equal amounts of the helper construct pCD/NL-BH (8),
the envelope construct pLTR-G (9) and the transfer construct
containing the desired transgene were transiently transfected
into HEK293-T cells and the virus-enriched cell supernatant
was collected 3 days later, ®ltered and frozen in aliquots.
pLEGFP-N1-derived GFP-encoding oncoretrovirus was pro-
duced using the Retro-X Expression System (BD Biosciences,
Palo Alto, CA) according to the manufacturer's protocols.
RESULTS
Lentiviral expression cloning/screening for the discovery
of proliferation-inducing genes
In order to identify novel growth-promoting genes we have
developed a cDNA library screening system based on the
sequential combination of two expression technologies:
transduction of proliferation-inert cells or tissues using a
lentiviral cDNA expression library, followed by selection of
proliferation-competent cells targeted by a GFP-encoding
oncoretrovirus. Figure 1A depicts key steps of the screening
strategy. (i) Transduction of proliferation-inert primary target
cells by a lentiviral cDNA expression library at speci®c m.o.i.
enables expression of one or several cDNAs per cell. A single
cDNA or a combinatorial effect of a particular gene pool of
the transduced cDNAs may trigger target cell proliferation.
(ii) Selection of mitotically active transgenic target cells using
a GFP-encoding reporter oncoretrovirus. Since oncoretro-
viruses selectively infect dividing cells they can be used to
monitor cell-cycle re-entry of primary cells following
transduction of a lentiviral cDNA expression library.
(iii) FACS-mediated cell sorting enables isolation of trans-
genic GFP-positive proliferating cells. (iv) Following clonal
expansion of GFP- and cDNA-expressing cells, proliferation
inducing transgene(s) are recovered from chromosomal
prolentiviruses by PCR-mediated ampli®cation using primers
complementary to heterologous cDNA-¯anking sequences.
Since RNA synthesis represents a key step in the retroviral
life cycle, the desired transgene expression unit integrated into
a retroviral transduction con®guration should be devoid of
any 5¢±3¢ poly(A) signals. Figure 1B shows a schematic
representation of the lentivirus-derived transfer vector pDC32
engineered to support expression of a poly(A) signal-contain-
ing cDNA insert. The pMF388 (6) derivative pDC32 is size-
optimized and contains a strong constitutive promoter derived
from the human cytomegalovirus immediate early promoter
(PhCMV) in 3¢±5¢ orientation. PhCMV is ¯anked by cis-acting
viral elements including the extended packaging signal (Y+)
as well as 5¢ and 3¢ long terminal repeats (LTR). Since poly(A)
signals are known to function in an orientation-dependent
Figure 1. Schematic representation of lentiviral expression cloning for the
discovery of proliferation-inducing cDNAs. (A) Proliferation-inert primary
cells are transduced by a lentiviral cDNA library at desired m.o.i.
Depending on the chosen m.o.i. a single gene or a transgene pool will be
expressed in the target cells. Only in the event that the transgene(s) triggers
proliferation of a primary cell can it be targeted by a GFP-encoding onco-
retrovirus and isolated by FACS-mediated single-cell cloning. Proliferation-
inducing cDNAs are recovered from the chromosome by PCR-mediated
ampli®cation from ¯anking lentiviral sequences. (B) Genetic con®guration
of the self-inactivating (3¢ LTRDU3) lentiviral expression vector pDC32
used for construction of the cDNA library. The cDNA expression cassette is
placed antisense to the 5¢ LTR in order to prevent interference of the poly-
adenylation site (pA) with reverse transcription. Following directional
cloning of the cDNA inserts into the NotI/PmlI sites, the NotI site survives
insertion into pDC32. Black arrows indicate oligonucleotides (ODC3 and
ODC4) required for PCR-mediated recovery of integrated cDNAs. The
extended lentiviral packaging signal is indicated (Y+).
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manner they are not expected to interfere with reverse
transcription when placed in antisense orientation. In addition,
due to a deletion in the 3¢ LTR, pCD32-derived lentivectors
are self-inactivated, preventing any 5¢ LTR-based interference
with expression of the cDNA or endogenous genes adjacent to
the chromosomal insert. In order to validate the pDC32-based
lentiviral expression con®guration, a GFP-encoding expres-
sion cassette (PhCMV-gfp-pA) was inserted into pDC32
followed by production and transduction of transgenic
lentiviral particles into CHO-K1 cells. Based on ¯uorescence
microscopy, close to 50% of the transduced cells scored
positive for GFP expression (data not shown), thus con®rming
that 3¢±5¢ orientation of the expression cassette is compatible
with lentivirus production and enables ef®cient transgene
expression. Next, a ds cDNA library synthesized from adult
human brain total RNA was cloned into pDC32. The oligo-
d(T) used for priming of ®rst strand synthesis contained a NotI
restriction endonuclease site to enable directional cloning into
pDC32. Over 4 3 105 independent clones were obtained,
pooled and their plasmid DNA isolated. The puri®ed
lentivector DNA was used to produce a library of lentiviral
particles containing PhCMV-driven adult human brain cDNAs.
The virus titer determined using a p24 immunoassay was
127.4 6 15.1 ng/ml correlating with 2±3 3 107 infectious
particles per ml.
Isolation of proliferation-promoting determinants
In order to identify novel proliferation-inducing genes,
mitotically quiescent HUVECs were transduced with a
lentivirus library transgenic for adult human brain cDNAs at
m.o.i. up to 10. Three days post-transduction, the cells were
retransduced using a GFP-encoding oncoretrovirus pLEGFP-
N1, which exclusively targets HUVECs that underwent cell-
cycle re-entry. pLEGFP-N1-transduced cell populations were
gated for GFP expression and single cell-sorted by FACS 48 h
post pLEGFP-N1 transduction. Single GFP-expressing cells
were seeded onto 96-well cell culture plates and allowed to
expand. Out of 12 GFP-expressing cell clones, three survived
triple passage and expansion indicating that they were
transduced by lentiviruses encoding proliferation-inducing
genes. Genomic DNA was extracted from the transgenic
proliferation-competent HUVEC cell derivatives and a
chromosomally integrated library cDNA could be PCR-
ampli®ed from a single clone using primers ODC3 and
ODC4 (Fig. 1B). The DNA fragment was cloned into
the mammalian expression vector pcDNA3.1 to yield
pPCR102-2. pPCR102-2 was found to contain a unique
novel sequence spanning about 300 nucleotides ¯anked by the
expected lentivector stretches (Fig. 2). The deduced amino
acid sequence of the cDNA insert of pPCR102-2 revealed an
open reading frame (ORF) of 297 bp coding for a putative
protein of 10 kDa. Sequence similarity searches in the human
genome database revealed an overall 39% homology of the
deduced polypeptide to the hypothetical human protein
XP_086050 on chromosome 19 (19p13.11).
Characterization of a novel proliferation-inducing cDNA
In order to demonstrate whether expression of the pPCR102-
2-encoded polypeptide can induce proliferation, we quanti®ed
GFP-mediated ¯uorescence of pPCR102-2-transfected
HUVECs following transduction with pLEGFP-N1. Since
pLEGFP-N1 can integrate only into chromosomes of pro-
liferating cells, GFP ¯uorescence levels correlate with the
number of proliferation-competent cells in transgenic HUVEC
populations. Figure 3A shows FACS-assessed GFP-mediated
¯uorescence levels of HUVECs, transfected either with
pPCR102-2 or an isogenic control vector (pcDNA3.1/V5-
His-TOPO), 48 h post-transduction with pLEGFP-N1. We
observed that pPCR102-2-transfected HUVEC populations
showed up to 15-fold higher green ¯uorescence levels
compared to control cells. In order to exclude that prolifer-
ation was induced by interference of a non-coding RNA
transcribed from the viral DNA encoded on pPCR102-2 clone,
we have created several pPCR102-2 derivatives containing
truncated/modi®ed cDNA inserts. In pND-A8 viral sequences
5¢ of the putative ORF were deleted (Fig. 2). The FACS
analysis of HUVECs, transfected with either pND-A8 or
isogenic control DNA and subsequently transduced with
pLEGFP-N1 revealed nearly 6-fold higher proliferation rate in
pND-A8-transfected cells compared to control cell popula-
tions (Fig. 3B). Furthermore, pND-A2 lacking viral sequences
as well as the putative ATG start codon of the ORF shows no
proliferation-modulating effects on HUVECs (Fig. 3C).
Finally, we have tagged the 297 bp-long ORF by fusing it
N-terminally to a His-tag and a TAA STOP codon (Fig. 2,
pPI1-His). FACS analysis of the pLEGFP-N1-transduced
HUVECs revealed that cells pretransfected with pPI1-His
showed a 4-fold higher GFP-mediated ¯uorescence compared
to HUVEC populations transfected with the control vector
(Fig. 3D). The overall reduction in proliferation-inducing
potential associated with elimination of viral sequences may
result from transcription- and/or translation-enhancing
activites contained in cis-acting viral sequences. All results
are consistent with the fact that the unique cDNA fragment
Figure 2. Structure of pPCR102-2 and its derivatives encoding different
modules of the proliferation-inducing cDNA. In pPCR102-2, the novel pro-
liferation-inducing cDNA is ¯anked by viral sequences and contains an
ORF. In order to narrow down the proliferation-inducing ORF, we con-
structed pND-A8 containing 5¢ deletions of viral sequences, pND-A2
harboring a deletion of the ATG start codon of ORF and pPI1-His encoding
full-length PI1 ORF fused in-frame to a histidine tag. pPCR102-2 deriva-
tives were produced by deleting sequences either upstream or including the
putative start ATG of the ORF. All constructs were cloned under control of
PhCMV.
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contained on pPCR102-2 encodes a polypeptide able to induce
proliferation in HUVECs, which we call PI1 (proliferation
inducer 1). Indeed, conditional IPTG-induced expression of
His-tagged piI in Escherichia coli resulted in production of a
single 15 kDa (15 kDa, PI1 plus His-tag; 10 kDa PI1 only)
protein following 4 h of IPTG induction (Fig. 4).
PI1-induced cell proliferation
In order to quantify the direct impact of the PI1 on DNA
synthesis of mammalian cells we have performed Brd-uridine
incorporation-based cell proliferation assays. HUVECs trans-
fected with the pPI1-His showed enhanced Brd-uridine
incorporation in comparison with mock-transfected cells
which indicates increased proliferation (Fig. 5A). Increases
in DNA synthesis ranged from 20 to 80%, depending on the
cell density on the day of transfection. Similar results were
obtained in Swiss3T3 ®broblasts (Fig. 5B). When PI1 was
expressed in con¯uent cells it was unable to increase
proliferation indicating that PI1 is not an oncogene (Fig. 5A
and B).
DISCUSSION
Gene-function analysis is one of the key scienti®c activities in
the post-genomic era. Many genes are only expressed in small
quantities, at speci®c times during development or in a subset
of tissues. Based on their (i) high transduction ef®ciency,
(ii) stable integration into the host chromosome, (iii) broad
tissue tropism following pseudotyping and (iv) their capacity
to target mitotically inactive cells (10±14), we designed a
novel lentiviral expression cloning strategy for the detection of
proliferation-inducing determinants. As exempli®ed by clon-
ing of PI1 cDNA the discovery of novel proliferation-inducing
determinants using lentiviral expression cloning consists of
three consecutive steps. (i) Transduction of a lentiviral cDNA
produced from tissues containing proliferation-competent
cells into proliferation-inert target cells. (ii) Targeting,
isolation and expansion of cDNA expressing proliferating
cell clones using a reporter gene-encoding oncoretrovirus
which exclusively transduces mitotically active cells.
(iii) Cloning of chromosomal cDNA inserts by PCR-mediated
ampli®cation from ¯anking viral sequences.
Our initial decision to screen for proliferation-inducing
genes using a human brain cDNA expression library in order
to validate lentiviral expression cloning was based on recent
Figure 4. Expression of the PI1 protein. Escherichia coli transgenic for
pDC106 harboring PI1-His (see Fig. 2) under control of the IPTG-inducible
Plac promoter was grown for 4 h in the presence (+) or absence (±) of IPTG.
Cell lysates were resolved on SDS±PAGE and analyzed for PI1-His
production by His-tag-targeted immunodetection.
Figure 3. Proliferation-inducing capacity of pPCR102-2 and derivatives in HUVECs. HUVECs were transiently transfected with either pPCR102-2 (A), pND-
A8 (B), pND-A2 (C) or pPI1-His (D) in order to assess their proliferation-inducing potential. Forty-eight hours post transfection, the cell populations were
transduced with a GFP-encoding oncoretroviral vector, which exclusively targets proliferating cells. Forty-eight hours post-transduction, GFP-mediated
¯uorescence was quanti®ed by FACS. Fluorescence values were calculated by multiplying the number of GFP-expressing cells by the average intensity of
GFP expression. The relative ¯uorescence units were obtained by comparison with GFP-mediated ¯uorescence control populations (cntrl) transfected with
isogenic pcDNA3.1/V5-His-TOPO. Corresponding FACS histograms are also shown. All values are representative of at least three independent experiments.
FS, forward scatter; FL, ¯uoresence.
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®ndings suggesting that adult human brain cells have the
potential to divide and differentiate into neurons (15). There is
now abundant evidence that neural stem cells persist in the
adult brain and support ongoing neurogenesis in restricted
regions of the central nervous system (16). However, genes
triggering neurogenesis in the adult brain remain to be
identi®ed. Cloning of proliferation-inducing determinants
from adult human brain cells is expected to signi®cantly
advance the understanding of naturally occurring neuro-
genesis and will open new perspectives for treatment of
neurodegenerative disorders including Parkinson's and
Alzheimer's diseases. Animal models have substantiated the
fact that immature neural precursors can replace lost neurons,
restore their function and promote brain self-repair. Ongoing
clinical trials for the treatment of Parkinson's disease are
promising and increase hope that pioneering therapeutic
strategies established in animal models could be used for the
treatment of neurodegenerative diseases (17,18).
An inherent challenge for cloning of proliferation-inducing
cDNAs using retroviral systems is their capacity to induce
uncontrolled transgene-independent growth as a result of
random integration into the target chromosome. In order to
minimize unspeci®c growth-induction it is essential that the
target cells are proliferation-inert which is the case for most
differentiated primary cells. Our results using HUVECs as a
proliferation-inert reporter cell line exempli®es the possibility
of isolating growth-promoting genes in a single screening step.
PI1 is a 10 kDa protein that induces proliferation in sparse
HUVEC and Swiss3T3 ®broblast cultures while it shows no
growth-promoting effect on con¯uent cells. The ®nding that
contact inhibition seems to be dominant over PI1 action
suggests that this protein lacks transformation potential. PI1
might therefore be considered for expansion of primary cells
in tissue engineering scenarios that require timely growth
induction without becoming neoplastic.
The use of lentiviral cDNA expression libraries is not
limited to screening for growth-inducing genes. The same
library could be used to discover genes involved in any cell
phenotype-modulating process as long as there are tools to
detect desired cell phenotypes. With the cloning of PI1,
lentiviral expression cloning has become a molecular reality
and the newest chapter in the success story of expression
technology. Taking advantage of pantropic transduction
capacity and the ability to deliver transgenes into non-
proliferating primary cells, lentiviral expression cloning is
expected to enable a new dimension in gene discovery and
gene-function analysis in the post genomic era.
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